Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine

NCT06485752 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Decided to not move forward with the study

Conditions

Interventions

Sponsor

Novavax